메뉴 건너뛰기




Volumn 5, Issue 9, 2010, Pages 390-396

Antibacterial drug discovery in the age of resistance

Author keywords

[No Author keywords available]

Indexed keywords


EID: 79952950158     PISSN: 15587452     EISSN: 15587460     Source Type: Journal    
DOI: 10.1128/microbe.5.390.1     Document Type: Article
Times cited : (11)

References (9)
  • 3
    • 46849089254 scopus 로고    scopus 로고
    • Recent developments in fragment-based drug discovery
    • Congreve, M., G. Chessari, D. Tisi, and A. J. Woodhead. 2008. Recent developments in fragment-based drug discovery. J. Med. Chem. 51:3661-3680.
    • (2008) J. Med. Chem , vol.51 , pp. 3661-3680
    • Congreve, M.1    Chessari, G.2    Tisi, D.3    Woodhead, A.J.4
  • 4
    • 69549111337 scopus 로고    scopus 로고
    • Antibiotics for Emerging Pathogens
    • Fischbach, M. A., and C. T. Walsh. 2009. Antibiotics for Emerging Pathogens. Science 325:1089-1093.
    • (2009) Science , vol.325 , pp. 1089-1093
    • Fischbach, M.A.1    Walsh, C.T.2
  • 5
    • 0038779250 scopus 로고    scopus 로고
    • Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes
    • Gentry, D. R., K. A. Ingraham, M. J. Stanhope, S. Rittenhouse, R. L. Jarvest, P. J. O'Hanlon, J. R. Brown, and D. J. Holmes. 2003. Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes. Antimicrob. Agents Chemother. 47:1784-1789.
    • (2003) Antimicrob. Agents Chemother , vol.47 , pp. 1784-1789
    • Gentry, D.R.1    Ingraham, K.A.2    Stanhope, M.J.3    Rittenhouse, S.4    Jarvest, R.L.5    O'Hanlon, P.J.6    Brown, J.R.7    Holmes, D.J.8
  • 6
    • 75549091422 scopus 로고    scopus 로고
    • Monnet on behalf of participating members of the European Society of Intensive Care Medicine (ESICM). 2009. Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009
    • on behalf of participating members of the European Society of Intensive Care Medicine (ESICM)
    • Lepape, A., and D. L. Monnet on behalf of participating members of the European Society of Intensive Care Medicine (ESICM). 2009. Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009. Eurosurveill. 14(45):4-6.
    • (2009) Eurosurveill , vol.14 , Issue.45 , pp. 4-6
    • Lepape, A.1    Monnet, D.L.2
  • 7
    • 75449086103 scopus 로고    scopus 로고
    • Discovery of novel ntibacterials. Expert Opin
    • Miller, J. R., and G. L. Waldrop. 2010. Discovery of novel ntibacterials. Expert Opin. Drug Disc. 5:145-154.
    • (2010) Drug Disc , vol.5 , pp. 145-154
    • Miller, J.R.1    Waldrop, G.L.2
  • 8
    • 43949129098 scopus 로고    scopus 로고
    • Physicochemical properties of antibacterial compounds: Implications for drug discovery
    • O'Shea, R., and H. E. Moser. 2008. Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51:2871-2877.
    • (2008) J. Med. Chem , vol.51 , pp. 2871-2877
    • O'Shea, R.1    Moser, H.E.2
  • 9
    • 33845903833 scopus 로고    scopus 로고
    • Drugs for bad bugs: Confronting the challenges of antibacterial discovery
    • Payne, D. J., M. N. Gwynn, D. J. Holmes, and D. L. Pompliano. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Rev. Drug Disc. 6:29-40.
    • (2007) Nature Rev. Drug Disc , vol.6 , pp. 29-40
    • Payne, D.J.1    Gwynn, M.N.2    Holmes, D.J.3    Pompliano, D.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.